Rozek Elizabeth bought SGMT
February 19, 2026 · Form 4 insider transaction
Rozek Elizabeth bought 44,000 shares of Sagimet Biosciences Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
44,000
Price
$0.00
Total value
N/A
InsiderRozek Elizabeth
RoleOfficer
SecuritySeries A Common Stock
Transaction codeA: Grant or award
Transaction dateFebruary 19, 2026
Filing dateFebruary 20, 2026
Shares owned after234,959
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Series A Common Stock upon vesting and settlement. The RSUs shall vest over four equal annual installments following February 19, 2026, subject to the Reporting Person's continued service on each such vesting date.